ALYFTREK 10 mg/50 mg/125 mg cpr pellic 56 pce

7680693980020 CH-69398 R07AX33 03.99.0.

No images available

Details

Product number
6939802
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
vanzacaftorum 10 mg ut vanzacaftorum hemicalcicum monohydricum 10.60 mg, tezacaftorum 50 mg, deutivacaftorum 125 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, E 171, talcum, E 120, E 133, E 172 (rubrum), pro compresso obducto corresp. natrium 2.16 mg.

Articles (1)

Alyftrek 10 mg/ 50 mg/ 125 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/08/2026
Patient information leaflet
Français
21/08/2026
Patient information leaflet
Italien
21/08/2026
Professional SmPC
Allemand
21/08/2026
Professional SmPC
Français
21/08/2026
Professional SmPC
Italien
21/08/2026

Detailed composition

Substance Quantity Type Category
vanzacaftorum
10.0 MG Substance Wirkstoff (Principe actif)
vanzacaftorum hemicalcicum monohydricum
10.6 MG Substance WIZUS
tezacaftorum
50.0 MG Substance Wirkstoff (Principe actif)
deutivacaftorum
125.0 MG Substance Wirkstoff (Principe actif)
hypromellosum
- Substance HNIDK
hypromellosi acetas succinas
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
carmellosum natricum conexum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
E 171
- Substance FNIDK
talcum
- Substance HNIDK
E 120
- Substance FIMDK
E 133
- Substance FIMDK
E 172 (rubrum)
- Substance FTODK
natrium
2.16 MG Substance HBESI

Reimbursement information

Public price
CHF 15038.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Vertex Pharmaceuticals (CH) GmbH

6300 Zug

Authorization information

Swissmedic authorization number
69398
Drug name
Alyftrek, Filmtabletten
Galenic form
FILM
ATC Code
R07AX33
Authorization status
Z
Dispensation category
A
First authorization
15/10/2025
Authorization expiration date
14/10/2030
IT number
03.99.0.
Domain
Human medicine
Field of application
Zystische Fibrose

Packaging details

Description (FR)
ALYFTREK 10 mg/50 mg/125 mg cpr pellic 56 pce
Description (DE)
ALYFTREK 10 mg/50 mg/125 mg Filmtabl 56 Stk
Market launch
15/10/2025
Narcotic (BTM)
No

Other packaging sizes

ALYFTREK 4 mg/20 mg/50 mg cpr pellic 84 pce
84 TABL
View
Buy us a coffee Explore the data